Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2011-002294-29Phase 4Completed
Phase 4, open-label trial of propofol and sevoflurane (2 arms), sponsored by Fundación Investigación Biomédica Hospital General Universitario Gregorio Marañón. Primary endpoint: Inflammatory mediators in serum and bronchoalveolar lavage. Started Feb 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2011-002294-29.